Background and Objective: Imatinib mesylate is the first effective therapy for advanced unresectable gastrointestinal stromal tumours (GIST). Adoption of this therapy in clinical practice is partly ...
Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing KIT Seven ...
Treatment of sclerodermatous chronic GVHD (cGVHD) remains disappointing. Imatinib mesylate enables selective, dual inhibition of the transforming growth factor Ī² (TGFĪ²) and PDGF pathways. Recently, ...
Imatinib is an oral targeted therapy used for several cancers and other conditions caused by specific genetic mutations. The medication is approved for: Philadelphia chromosome positive chronic ...
Imatinib mesylate (Gleevec [Glivec], Novartis), a protein kinase inhibitor of c-kit receptor tyrosine kinase (KIT) and platelet-derived growth factor receptor Ī± (PGFR-Ī±), is widely used for the ...
Lack of Effect of a Low-Fat, High-Fruit, -Vegetable, and -Fiber Diet on Serum Prostate-Specific Antigen of Men Without Prostate Cancer: Results From a Randomized Trial PURPOSE: Dermatofibrosarcoma ...
Novartis announced new 24-month data from its Phase 3 trial comparing Tasigna (nilotinib) 150mg capsules to Gleevec (imatinib mesylate, from Novartis) tablets in the treatment of adult patients with ...
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any ...
Company eligible for 180-days marketing exclusivity on a first-to-file Para-IV ANDA Mumbai, December 04, 2015: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, ...
Imatinib acts through selective inhibition of tyrosine kinases, which are constitutively activated in a number of cancers. Some of the drug's adverse reactions are presumably caused by the inhibition ...
Clin Drug Invest. 2007;27(2):85-93. Because the costs associated with GIST treatment have also not been rigorously studied, these model inputs were estimated by reference to expert opinion regarding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results